CRISPR/Cas9 Strategy for Correcting ELANE Mutations and Restoring Neutrophil Differentiation in Severe Congenital Neutropenia: Insights from Patient-Derived iPSCs

被引:0
|
作者
Rydzynska, Zuzanna [1 ]
Grzela, Dawid [1 ,2 ]
Linder, Monika I. [3 ]
Dobrewa, Weronika [1 ]
Urbanska, Zuzanna [1 ]
Pawlik, Bartlomiej [1 ]
Krzyzanowski, Damian [1 ,2 ]
Mazurek, Maciej [1 ]
Janczar, Szymon [1 ]
Madzio, Joanna [1 ]
Mlynarski, Wojciech [1 ]
机构
[1] Med Univ Lodz, Dept Pediat Oncol & Hematol, Lodz, Poland
[2] Polish Acad Sci, Inst Med Biol, Lodz, Poland
[3] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany
关键词
D O I
10.1182/blood-2023-188759
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 21 条
  • [21] Generation of gene corrected human isogenic iPSC lines (IDVi003-A_CR13, IDVi003-A_CR21, IDVi003-A_CR24) from an inherited retinal dystrophy patient-derived IPSC line ITM2B-5286-3 (IDVi003-A) carrying the ITM2B c.782A > C variant using CRISPR/Cas9
    Yacoub, Tasnim Ben
    Letellier, Camille
    Wohlschelegel, Juliette
    Condroyer, Christel
    Goureau, Olivier
    Zeitz, Christina
    Audo, Isabelle
    STEM CELL RESEARCH, 2023, 71